000			01839 a2200541 4500
005			20250516134858.0
264		0	_c20140417
008			201404s 0 0 eng d
022			_a2040-2058
024	7		_a10.3851/IMP2525 _2doi
040			_aNLM _beng _cNLM
100	1		_aHermans, Sabine M
245	0	0	_aRisk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting. _h[electronic resource]
260			_bAntiviral therapy _c2013
300			_a615-22 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAlkynes
650	0	4	_aAnti-HIV Agents _xadverse effects
650	0	4	_aAntiretroviral Therapy, Highly Active
650	0	4	_aBenzoxazines _xadverse effects
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aCD4-Positive T-Lymphocytes _xdrug effects
650	0	4	_aCohort Studies
650	0	4	_aComorbidity
650	0	4	_aCyclopropanes
650	0	4	_aFemale
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV-1 _xdrug effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMycobacterium tuberculosis _ximmunology
650	0	4	_aNevirapine _xadverse effects
650	0	4	_aProportional Hazards Models
650	0	4	_aRisk Factors
650	0	4	_aSurvival Analysis
650	0	4	_aTuberculosis, Pulmonary _xetiology
650	0	4	_aUganda _xepidemiology
650	0	4	_aViral Load _xdrug effects
700	1		_aManabe, Yukari C
700	1		_aKiragga, Agnes N
700	1		_aHoepelman, Andy I M
700	1		_aLange, Joep M A
700	1		_avan Leth, Frank
773	0		_tAntiviral therapy _gvol. 18 _gno. 4 _gp. 615-22
856	4	0	_uhttps://doi.org/10.3851/IMP2525 _zAvailable from publisher's website
999			_c22517823 _d22517823